Artigo Revisado por pares

Abnormalities of Circulating T Cell Subsets in Atopy: Influence of Specific Immunotherapy

1983; Karger Publishers; Volume: 71; Issue: 4 Linguagem: Inglês

10.1159/000233411

ISSN

1423-0097

Autores

Giorgio Walter Canonica, W. Dirienzo, Elisabetta Cosulich, Silvano Ferrini, Giorgio Ciprandi, Giovanni Melioli,

Tópico(s)

IL-33, ST2, and ILC Pathways

Resumo

Blood samples of patients with severe respiratory allergic diseases contain increased numbers of T cells bearing surface HLA-DR antigens, indicating the presence of activated T cells. In the same group of patients, MLR3 and MLR4, two monoclonal antibodies (Mab) directed to subsets of activated peripheral T cells, recognize T cell percentages within the normal range. Thus, it seems possible that specialized subsets of activated T cells (HLA-DR<sup>+</sup>/MLR3-MLR4<sup>––</sup>) are represented in the peripheral blood of atopic patients. Such cells are lacking in patients after specific imunotherapy. Similar results – an increased percentage of 5/9<sup>+</sup> T cells in untreated patients and normal counts of 5/9<sup>+</sup> T cells in treated ones – were obtained in the two groups of patients by using another Mab, 5/9, which serves as a reliable marker of helper T cells in resting peripheral T lymphocytes. These data further support the concept of a T cell imbalance in allergic patients and suggest a possible role of specific immunotherapy in correcting the modification of peripheral T cell abnormalities.

Referência(s)